Close Menu

On his blog, DrugMonkey discusses the argument that junior reviewers become bogged down in the details in study sections and don't focus on the quality of the science. DrugMonkey says some of these complaints may be due to how less established scientists think or are taught study sections and reviews should go, based upon the feedback they have themselves received.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.